Effect of transfected interleukin-6 in non-tumorigenic and tumorigenic rat urothelial cell lines

International Journal of Cancer

Volumn 68, Issue 5, 1996, Pages 616-621

  Okamoto, Masato ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CARCINOGENICITY; CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR XENOGRAFT; UROTHELIUM;

ANIMALS; CARCINOMA; CELL DIVISION; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-6; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0029827529     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961127)68:5<616::AID-IJC11>3.3.CO;2-K     Document Type: Article

References (17)

1. BORSELLINO, N., BELLDEGRUN, A. and BONAVIDA, B., Endogenous interleukin 6 is a resistance factor for cis-diamminedichlorpplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res., 55, 4633-1639 (1995).
2. DE REIJKE, T.M., Vos, P.C.N., DE VOER, E.G., BEVERS, R.F.M., DE MUINCK KEIZER, W.H., KURTH, K.H. and SCHAMIIART, D.H.J., Cytokine production by the human bladder-carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG). Urol Res., 21, 349-352 (1993).
3. EUSTACE, D., HAN, X., GOODING, R., ROWBOTTOM, A., RICHES, P. and HEYDERMAN, E., Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas m vitro. Gynecol. Oncol., 50, 15-19 (1993).
4. HELGREN, M.E., SQUINTO, S.P., DAVIS, H.L., PARRY, D.J., BOULTON, T.G., HECK, C.S., ZHU, Y., YANCOPOULOS, G.D., LINDSAY, R.M. and Di STEFANO, P.S., Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell, 76, 493-504 (1994).
5. KAWAI, K., KAWAMATA, H., KAMEYAMA, S., RADEMAKER, A. and OYASU, R., Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus. Cancer Res., 54, 2630-2632 (1994).
6. KAWAI, K., YAMAMOTO, M., KAMEYAMA, S., KAWAMATA, H., RADEMAKER, A. and OYASU, R., Enhancement of rat urinary-bladder tumorigenesis by lipopolysaccharide-induced inflammation. Cancer Res., 53, 5172-5175(1993).
7. KAWAMATA, H., KAMEYAMA, S., NAN, L., KAWAI, K. and OYASU, R., Effect of epidermal growth factor and transforming growth factor β1 on growth and invasive potentials of newly established rat bladdercarcinoma cell lines. Int. J. Cancer, 55, 968-973 (1993).
8. KISHIMOTO, T., The biology of interleukin-6. Blood, 74, 1-10 (1989).
9. Lu, C. and KERBEL, R.S., Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.J. CellBiol, 120, 1281-1288 (1993).
10. MIKI, S., IWANO, M., MIKI, Y., YAMAMOTO, M., TANG, B., YOKOKAWA, K., SONODA, T., HIRANO, T. and KISHIMOTO, T., Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal-cell carcinomas. FEBS Lett., 250, 607-610 (1989).
11. OKAMOTO, M., KAWAMATA, H., KAWAI, K. and OYASU, R., Enhancement of transformation in vitro of a non-tumorigenic rat urothelial cell line by interleukin-6. Cancer Res., 55, 4581-1585 (1995).
12. OYASU, R., MANNING, D.J., MATSUMOTO, M. and Hopp, M.L., Heterotopic urinary bladder with a communicating reservoir. Cancer Res., 36, 2261-2267 (1976).
13. SEGUCHI, T., YOKOKAWA, K., SUGAO, H., NAKANO, E., SONODA, T. and OKUVAMA, A., Interleukin-6 activity in urine and serum in patients with bladder carcinoma.J. Urol., 148, 791-794(1992).
14. TAGA, T., HIBI, M., HIRATA, Y., YAMASAKI, K., YASUKAWA, K., MATSUDA, T., HIRANO, T. and KISHIMOTO, T., Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell, 58, 573-581(1989).
15. TAKENAWA, J., KANEKO, Y., FUKUMOTO, M., FUKATSU, A., HIRANO, T., FUKUYAMA, H., NAKAYAMA, H., FUJITA, J. and YOSHIDA, O., Enhanced expression of interleukin-6 in primary human renal carcinomas. J, not. Cancer Inst., 83, 1668-1672 (1991).
16. TAM, I., CARDINALE, I., KRUEGER, J., MURPHY, J.S., MAY, L.T. and SEHOAL, P.B., Interleukin-6 decreases cell-cell association and increases motility of ductal breast-carcinoma cells. J. exp. Med., 170, 1649-1669 (1989).
17. YAMAMOTO, M., Wu, H., MOMOSE, H., RADEMAKER, A. and OYASU, R., Marked enhancement of rat urinary-bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res., 52, 5329-5333 (1992).